Cathay Biotech (China) Price on October 19, 2023

688065 Stock   37.76  0.04  0.11%   
Below is the normalized historical share price chart for Cathay Biotech extending back to August 12, 2020. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Cathay Biotech stands at 37.76, as last reported on the 10th of January, with the highest price reaching 38.17 and the lowest price hitting 37.53 during the day.
200 Day MA
43.2986
50 Day MA
44.5114
Beta
0.627
 
Covid
If you're considering investing in Cathay Stock, it is important to understand the factors that can impact its price. Cathay Biotech secures Sharpe Ratio (or Efficiency) of -0.16, which signifies that the company had a -0.16% return per unit of risk over the last 3 months. Cathay Biotech exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Cathay Biotech's Risk Adjusted Performance of (0.17), standard deviation of 2.36, and Mean Deviation of 1.67 to double-check the risk estimate we provide.
  
As of January 10, 2025, Total Stockholder Equity is expected to decline to about 10.5 B. In addition to that, Common Stock Shares Outstanding is expected to decline to about 628.8 M. Cathay Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.1635

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative Returns688065

Estimated Market Risk

 2.27
  actual daily
20
80% of assets are more volatile

Expected Return

 -0.37
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.16
  actual daily
0
Most of other assets perform better
Based on monthly moving average Cathay Biotech is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Cathay Biotech by adding Cathay Biotech to a well-diversified portfolio.
Price Book
1.9325
Enterprise Value Ebitda
39.2707
Price Sales
7.9704
Shares Float
214.5 M
Dividend Share
0.19

Cathay Biotech Valuation on October 19, 2023

It is possible to determine the worth of Cathay Biotech on a given historical date. On October 19, 2023 Cathay was worth 52.69 at the beginning of the trading date compared to the closed value of 51.27. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Cathay Biotech stock. Still, in general, we apply an absolute valuation method to find Cathay Biotech's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Cathay Biotech where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Cathay Biotech's related companies.
 Open High Low Close Volume
  53.41    53.41    52.57    52.70    720,602  
10/19/2023
  52.69    53.03    51.18    51.27    1,355,435  
  50.88    51.90    50.76    51.22    1,003,305  
Backtest Cathay Biotech  |  Cathay Biotech History  |  Cathay Biotech Valuation   PreviousNext  
Open Value
52.69
51.27
Closing Value
59.49
Upside

Cathay Biotech Trading Date Momentum on October 19, 2023

On October 20 2023 Cathay Biotech was traded for  51.22  at the closing time. The highest price during the trading period was 51.90  and the lowest recorded bid was listed for  50.76 . The volume for the day was 1 M. This history from October 20, 2023 contributed to the next trading day price decline. The daily price change to the next closing price was 0.10% . The overall trading delta to the current price is 2.40% .

Cathay Biotech Fundamentals Correlations and Trends

By evaluating Cathay Biotech's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Cathay Biotech's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Cathay financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Cathay Biotech Stock history

Cathay Biotech investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Cathay is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Cathay Biotech will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Cathay Biotech stock prices may prove useful in developing a viable investing in Cathay Biotech
Last ReportedProjected for Next Year
Common Stock Shares Outstanding670.9 M628.8 M

Cathay Biotech Quarterly Net Working Capital

4.37 Billion

Cathay Biotech Stock Technical Analysis

Cathay Biotech technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Cathay Biotech technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Cathay Biotech trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Cathay Biotech Period Price Range

Low
January 10, 2025
0.00  NaN%
High

 0.00 

     

 0.00 

Cathay Biotech cannot be verified against its exchange. Please verify the symbol is currently traded on Shanghai Stock Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

Cathay Biotech January 10, 2025 Market Strength

Market strength indicators help investors to evaluate how Cathay Biotech stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Cathay Biotech shares will generate the highest return on investment. By undertsting and applying Cathay Biotech stock market strength indicators, traders can identify Cathay Biotech entry and exit signals to maximize returns

Cathay Biotech Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Cathay Biotech's price direction in advance. Along with the technical and fundamental analysis of Cathay Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Cathay to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Complementary Tools for Cathay Stock analysis

When running Cathay Biotech's price analysis, check to measure Cathay Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cathay Biotech is operating at the current time. Most of Cathay Biotech's value examination focuses on studying past and present price action to predict the probability of Cathay Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cathay Biotech's price. Additionally, you may evaluate how the addition of Cathay Biotech to your portfolios can decrease your overall portfolio volatility.
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Volatility Analysis
Get historical volatility and risk analysis based on latest market data